Rohan Ganesh

Rohan is a Partner at Obvious Ventures, where he invests in companies at the intersection of science, technology, and healthcare. He supports several companies as a board director or observer including Inceptive, Inato, Pi Health, Gandeeva Therapeutics, Anagenex, and LabGenius. Prior to joining Obvious, he led venture investments in healthcare technology, biotech, and diagnostics at Verily Life Sciences, a Google spinout, and at Northpond Ventures, a multi-billion-dollar science-driven venture firm. He worked as product manager for CompuGroup Medical (leading EMR company in Europe) and in Verily’s computer-aided disease detection and machine learning team.

Obvious Ventures
Wednesday
May 07
Machine Learning and Multiplexed Libraries for Large-Scale Synthetic Biology
9:25 AM

-

9:55 AM

Every major AI advance was built on massive amounts of data. ChatGPT was built on top of the Internet, new coding agents train on millions of public codebases, and AlphaFold leveraged the Protein DataBank. Learn about the ways that synthetic biologists are leveraging the combination of DNA sequencing and synthesis to fuel new modeling advances.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 18th

Full Rate:

$3,495

Other Speakers

Copyright SynBioBeta 2025